nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00439	0.00439	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Other—HTR2A—Parkinson's disease	0.00439	0.00439	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00414	0.00414	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00414	0.00414	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00406	0.00406	CbGpPWpGaD
Methacholine—CHRM3—Regulation of insulin secretion—INS—Parkinson's disease	0.00402	0.00402	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00402	0.00402	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00374	0.00374	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00371	0.00371	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.0037	0.0037	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00367	0.00367	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—GRM4—Parkinson's disease	0.00356	0.00356	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—GRM4—Parkinson's disease	0.00353	0.00353	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.0035	0.0035	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00347	0.00347	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—PENK—Parkinson's disease	0.00338	0.00338	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00337	0.00337	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—PENK—Parkinson's disease	0.00335	0.00335	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00328	0.00328	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00325	0.00325	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00324	0.00324	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00322	0.00322	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00321	0.00321	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00318	0.00318	CbGpPWpGaD
Methacholine—CHRM3—Integration of energy metabolism—INS—Parkinson's disease	0.00316	0.00316	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00314	0.00314	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00311	0.00311	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—PDYN—Parkinson's disease	0.00309	0.00309	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—PDYN—Parkinson's disease	0.00306	0.00306	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00304	0.00304	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00301	0.00301	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00299	0.00299	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00296	0.00296	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00293	0.00293	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00293	0.00293	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—GRM5—Parkinson's disease	0.00287	0.00287	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00285	0.00285	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00285	0.00285	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—GRM5—Parkinson's disease	0.00284	0.00284	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00278	0.00278	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00276	0.00276	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00275	0.00275	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00275	0.00275	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00274	0.00274	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00272	0.00272	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00272	0.00272	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00271	0.00271	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—DGKQ—Parkinson's disease	0.00269	0.00269	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GPR37—Parkinson's disease	0.00269	0.00269	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00269	0.00269	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GPR37—Parkinson's disease	0.00266	0.00266	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00266	0.00266	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00266	0.00266	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.0026	0.0026	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00258	0.00258	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00255	0.00255	CbGpPWpGaD
Methacholine—CHRM3—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00249	0.00249	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00246	0.00246	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00244	0.00244	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00244	0.00244	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00242	0.00242	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00235	0.00235	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00235	0.00235	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00233	0.00233	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00233	0.00233	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GRK5—Parkinson's disease	0.00225	0.00225	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00223	0.00223	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00222	0.00222	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ND3—Parkinson's disease	0.00213	0.00213	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MCCC1—Parkinson's disease	0.00213	0.00213	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HTR1A—Parkinson's disease	0.00212	0.00212	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.0021	0.0021	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—TAC1—Parkinson's disease	0.00209	0.00209	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.00207	0.00207	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—DRD1—Parkinson's disease	0.00205	0.00205	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GRK5—Parkinson's disease	0.00204	0.00204	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.00203	0.00203	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GRM4—Parkinson's disease	0.00201	0.00201	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—OMD—Parkinson's disease	0.002	0.002	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TALDO1—Parkinson's disease	0.002	0.002	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00199	0.00199	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—DRD3—Parkinson's disease	0.00198	0.00198	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.00196	0.00196	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00192	0.00192	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VPS35—Parkinson's disease	0.00192	0.00192	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PENK—Parkinson's disease	0.00191	0.00191	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00191	0.00191	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NDUFB11—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.00189	0.00189	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00187	0.00187	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GRM4—Parkinson's disease	0.00183	0.00183	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GCH1—Parkinson's disease	0.00181	0.00181	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.00181	0.00181	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—DRD2—Parkinson's disease	0.00179	0.00179	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HTR7—Parkinson's disease	0.00179	0.00179	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.00178	0.00178	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.00178	0.00178	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PDYN—Parkinson's disease	0.00175	0.00175	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PENK—Parkinson's disease	0.00173	0.00173	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00173	0.00173	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00169	0.00169	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00169	0.00169	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00165	0.00165	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00163	0.00163	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GRM5—Parkinson's disease	0.00162	0.00162	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—FBP1—Parkinson's disease	0.00162	0.00162	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—DBH—Parkinson's disease	0.00162	0.00162	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GBA—Parkinson's disease	0.00162	0.00162	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00161	0.00161	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—DGKQ—Parkinson's disease	0.00159	0.00159	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GPR37—Parkinson's disease	0.00159	0.00159	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PDYN—Parkinson's disease	0.00159	0.00159	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GRM5—Parkinson's disease	0.00147	0.00147	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	0.00146	0.00146	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00145	0.00145	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00138	0.00138	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00137	0.00137	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.00126	0.00126	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.00126	0.00126	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00125	0.00125	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00123	0.00123	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—DDC—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.00117	0.00117	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.00106	0.00106	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.00105	0.00105	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00105	0.00105	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.00104	0.00104	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00104	0.00104	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.001	0.001	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.001	0.001	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000998	0.000998	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000989	0.000989	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00095	0.00095	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000941	0.000941	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000937	0.000937	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000928	0.000928	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.00092	0.00092	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.00092	0.00092	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000911	0.000911	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000911	0.000911	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000881	0.000881	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000872	0.000872	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000871	0.000871	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000862	0.000862	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000811	0.000811	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000803	0.000803	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000773	0.000773	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000764	0.000764	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000756	0.000756	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000742	0.000742	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.00074	0.00074	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.000736	0.000736	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000733	0.000733	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000729	0.000729	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000728	0.000728	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000709	0.000709	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000703	0.000703	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.000683	0.000683	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000679	0.000679	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000677	0.000677	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000671	0.000671	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TH—Parkinson's disease	0.000661	0.000661	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.000646	0.000646	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000644	0.000644	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.000642	0.000642	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.00064	0.00064	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000638	0.000638	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000636	0.000636	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000635	0.000635	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000633	0.000633	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.000627	0.000627	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.00062	0.00062	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000614	0.000614	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000601	0.000601	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.000595	0.000595	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—COMT—Parkinson's disease	0.000562	0.000562	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000561	0.000561	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.00056	0.00056	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000558	0.000558	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000556	0.000556	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000552	0.000552	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000543	0.000543	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000543	0.000543	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.000538	0.000538	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.000538	0.000538	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.00053	0.00053	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000514	0.000514	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000493	0.000493	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000455	0.000455	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.000455	0.000455	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000451	0.000451	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.00044	0.00044	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.000436	0.000436	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000435	0.000435	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.000431	0.000431	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOE—Parkinson's disease	0.000423	0.000423	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.0004	0.0004	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	0.000396	0.000396	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000381	0.000381	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	0.000377	0.000377	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—INS—Parkinson's disease	0.000362	0.000362	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000354	0.000354	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	0.00035	0.00035	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INS—Parkinson's disease	0.000302	0.000302	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INS—Parkinson's disease	0.000299	0.000299	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	0.000225	0.000225	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	0.000224	0.000224	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	0.000223	0.000223	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	0.000221	0.000221	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	0.000207	0.000207	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	0.000205	0.000205	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	0.000132	0.000132	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	0.000131	0.000131	CbGpPWpGaD
